TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Maravai Lifesciences Holdings Inc (MRVI)

Healthcare Biotechnology
6.40 $
-2.3% vs. previous close
Closing price · As of: 3. Aug 2026

Maravai Lifesciences Holdings Inc (MRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 713 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet MRVI
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
2,264 2,268 1,487 1,445 1,448 1,278 1,008 960 897 849 771 713
699 701 700 668 685 679 429 376 360 326 296 252
580 580 575 562 573 578 322 285 270 244 217 166
580 580 575 562 573 578 322 285 270 244 217 166
49 49 56 40 39 29 39 28 28 23 25 33
47 49 51 50 49 50 50 50 47 45 40 40
207 – – – – – – – – – – –
326 326 326 326 326 172 160 160 129 129 129 129
235 228 221 214 207 202 195 200 193 186 152 145
1,367 1,375 698 667 671 665 431 429 429 417 398 344
75 78 87 59 69 63 57 63 70 62 45 43
13 13 13 13 13 13 14 6.3 6.3 5.4 5.4 5.4
6.7 9.4 11 8.2 13 9.5 12 9.5 12 8.0 2.9 8.5
520 520 519 518 517 516 290 289 288 287 286 236
521 519 417 411 437 345 325 301 266 245 212 212
398 392 286 274 266 167 141 111 71 46 10 6.4
132 132 132 132 136 142 140 143 144 145 145 146

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?